RH
RH7.F Ryman Healthcare Limited
- Market cap
- EUR 859M
- P/E
- -
- P/B
- 0.60x
- ROE
- -10.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2025.
Is RH7.F undervalued?
Graham numberThe Graham number of Ryman Healthcare Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ryman Healthcare Limited fundamental analysis
No fundamental analysis for Ryman Healthcare Limited yet.
Ryman Healthcare Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ryman Healthcare Limited
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.
Full company profileRyman Healthcare Limited financial statements
Ryman Healthcare Limited annual financial statements (NZD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 288M | 341M | 381M | 422M | 452M | 504M | 560M | 651M | 714M |
| Gross Profit | 288M | 341M | 381M | 422M | 452M | 504M | 560M | 651M | 714M |
| Operating Income | 48.0M | 52.0M | 54.1M | 44.2M | 24.7M | 1.82M | -19.8M | -69.6M | -118M |
| EBITDA | - | 426M | 371M | 219M | 462M | 788M | 458M | -50.7M | -27.2M |
| Net Income | 357M | 388M | 326M | 265M | 423M | 693M | 258M | 4.78M | -437M |
| EPS | 0.71 | 0.78 | 0.65 | 0.53 | 0.85 | 1.39 | 0.38 | 0.01 | -0.43 |
| Balance Sheet | |||||||||
| Total Assets | 4.94B | 5.80B | 6.65B | 7.68B | 9.17B | 11.0B | 12.5B | 13.1B | 12.1B |
| Total Liabilities | 3.29B | 3.86B | 4.48B | 5.38B | 6.34B | 7.53B | 7.85B | 8.67B | 7.80B |
| Shareholders' Equity | 1.65B | 1.94B | 2.17B | 2.30B | 2.83B | 3.43B | 4.66B | 4.42B | 4.26B |
| Cash & Short-term Investments | 0.00 | - | - | 34.4M | 20.2M | 28.3M | 27.9M | 41.8M | 17.7M |
| Cash Flow | |||||||||
| Operating Cash Flow | 323M | 349M | 401M | 450M | 413M | 586M | 651M | - | - |
| Capital Expenditure | 209M | 202M | 181M | 300M | 257M | 334M | 412M | 172M | 107M |
| Free Cash Flow | - | 164M | 244M | 175M | 184M | 287M | 327M | 486M | 303M |
| Ratios | |||||||||
| ROE | 21.6% | 20.0% | 15.0% | 11.5% | 15.0% | 20.2% | 5.5% | 0.1% | -10.3% |
| ROA | 7.2% | 6.7% | 4.9% | 3.4% | 4.6% | 6.3% | 2.1% | 0.0% | -3.6% |
| Net Profit Margin | 123.7% | 114.0% | 85.6% | 62.7% | 93.5% | 137.5% | 46.0% | 0.7% | -61.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ryman Healthcare Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 8, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | NZD 68.1M | 0.10 | 26.4% |
| 2022 | NZD 112M | 0.22 | 16.2% |
| 2021 | NZD 108M | 0.22 | 25.4% |
| 2020 | EUR 117M | 0.23 | 44.2% |
| 2019 | EUR 109M | 0.22 | 33.3% |
| 2018 | EUR 94.0M | 0.19 | 24.2% |
| 2017 | EUR 85.0M | 0.17 | 23.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ryman Healthcare Limited
- Insiders 12.13%
- Institutions 20.89%
- Public & others 66.98%
- Shares outstanding 1.02B
- Free float 1.00B
Ryman Healthcare Limited company profile
- Company name
- Ryman Healthcare Limited
- Ticker
- RH7.F
- ISIN
- NZRYME0001S4
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- March
- Address
- 92d Russley Road, Christchurch, New Zealand
- Phone
- 64 3 366 4069
- Website
- rymanhealthcare.co.nz
About Ryman Healthcare Limited
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.
Ryman Healthcare Limited management
9- Ms. Naomi M. James L.L.B., L.L.M., LLB (Hons), MLMChief Executive Officer · born 1978
- Mr. Matthew Thomas Prior B.Com., C.A.Chief Financial Officer
- Ms. Marsha E. CadmanChief Transformation & Strategy Officer and COO
- Mr. Hayden Stuart Strickett C.F.A.Head of Investor Relations
- Ms. Marie BonnemaisonChief Transformation & Corporate Development Officer
- Ms. Di WalshChief People & Safety Officer
- Mr. Rick DaviesChief Customer Officer
- Mr. Richard StephensonChief Property Officer
- Dr. Rachna Gandhi Ph.D.Chief Enterprise Strategy, Systems & Governance Officer